The molecular basis underlying T cell specificity towards citrullinated epitopes presented by HLA-DR4.
Humans
Mice, Transgenic
HLA-DR4 Antigen
/ immunology
Arthritis, Rheumatoid
/ immunology
Mice
Animals
Vimentin
/ immunology
CD4-Positive T-Lymphocytes
/ immunology
Citrullination
Phosphopyruvate Hydratase
/ immunology
Epitopes, T-Lymphocyte
/ immunology
Citrulline
/ metabolism
Receptors, Antigen, T-Cell
/ immunology
Epitopes
/ immunology
Crystallography, X-Ray
Receptors, Antigen, T-Cell, alpha-beta
/ genetics
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
23 Jul 2024
23 Jul 2024
Historique:
received:
09
09
2023
accepted:
12
07
2024
medline:
24
7
2024
pubmed:
24
7
2024
entrez:
23
7
2024
Statut:
epublish
Résumé
CD4
Identifiants
pubmed: 39043656
doi: 10.1038/s41467-024-50511-w
pii: 10.1038/s41467-024-50511-w
doi:
Substances chimiques
HLA-DR4 Antigen
0
Vimentin
0
Phosphopyruvate Hydratase
EC 4.2.1.11
Epitopes, T-Lymphocyte
0
Citrulline
29VT07BGDA
Receptors, Antigen, T-Cell
0
Epitopes
0
Receptors, Antigen, T-Cell, alpha-beta
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6201Informations de copyright
© 2024. The Author(s).
Références
Dendrou, C. A., Petersen, J., Rossjohn, J. & Fugger, L. HLA variation and disease. Nat. Rev. Immunol. 18, 325–339 (2018).
pubmed: 29292391
doi: 10.1038/nri.2017.143
Gregersen, P. K., Silver, J. & Winchester, R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205–1213 (1987).
pubmed: 2446635
doi: 10.1002/art.1780301102
Raychaudhuri, S. et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44, 291–296 (2012).
pubmed: 22286218
pmcid: 3288335
doi: 10.1038/ng.1076
Scally, S. W. et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J. Exp. Med. 210, 2569–2582 (2013).
pubmed: 24190431
pmcid: 3832918
doi: 10.1084/jem.20131241
Huizinga, T. W. et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 52, 3433–3438 (2005).
pubmed: 16255021
doi: 10.1002/art.21385
Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Arthritis Rheum. 62, 2569–2581 (2010).
pubmed: 20872595
doi: 10.1002/art.27584
Berglin, E. et al. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res. Ther. 6, R303 (2004).
pubmed: 15225365
pmcid: 464874
doi: 10.1186/ar1187
Kroot E-JJA et al. The prognostic value of anti–cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 43, 1831–1835 (2000).
doi: 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6
Van Gaalen, F. A. et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum. 50, 2113–2121 (2004).
pubmed: 15248208
doi: 10.1002/art.20316
Vossenaar, E. R. & van Venrooij, W. J. Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res. Ther. 6, 107–111 (2004).
pubmed: 15142259
pmcid: 416453
doi: 10.1186/ar1184
van Venrooij, W. J., van Beers, J. J. & Pruijn, G. J. Anti-CCP antibodies: the past, the present and the future. Nat. Rev. Rheumatol. 7, 391–398 (2011).
pubmed: 21647203
doi: 10.1038/nrrheum.2011.76
Suzuki, A. et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet 34, 395–402 (2003).
pubmed: 12833157
doi: 10.1038/ng1206
Curran, A. M., Naik, P., Giles, J. T. & Darrah, E. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets. Nat. Rev. Rheumatol. 16, 301–315 (2020).
pubmed: 32341463
doi: 10.1038/s41584-020-0409-1
Ting, Y. T. et al. The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis. J. Biol. Chem. 293, 3236–3251 (2018).
pubmed: 29317506
pmcid: 5836122
doi: 10.1074/jbc.RA117.001013
Hill, J. A. et al. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J. Immunol. 171, 538–541 (2003).
pubmed: 12847215
doi: 10.4049/jimmunol.171.2.538
Romero, V. et al. Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. Sci. Transl. Med. 5, 209ra150 (2013).
pubmed: 24174326
pmcid: 4032227
doi: 10.1126/scitranslmed.3006869
Darrah, E. & Andrade, F. Rheumatoid arthritis and citrullination. Curr. Opin. Rheumatol. 30, 72–78 (2018).
pubmed: 28937414
pmcid: 5848217
doi: 10.1097/BOR.0000000000000452
Derksen, V., Huizinga, T. W. J. & van der Woude, D. The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol. 39, 437–446 (2017).
pubmed: 28451788
pmcid: 5486798
doi: 10.1007/s00281-017-0627-z
Vossenaar, E. R. et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res. Ther. 6, R142–R150 (2004).
pubmed: 15059278
pmcid: 400433
doi: 10.1186/ar1149
Burkhardt, H. et al. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur. J. Immunol. 35, 1643–1652 (2005).
pubmed: 15832289
doi: 10.1002/eji.200526000
Masson-Bessiere, C. et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J. Immunol. 166, 4177–4184 (2001).
pubmed: 11238669
doi: 10.4049/jimmunol.166.6.4177
Kinloch, A. et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res. Ther. 7, R1421–R1429 (2005).
pubmed: 16277695
pmcid: 1297593
doi: 10.1186/ar1845
James, E. A. et al. Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy. Arthritis Rheumatol. 66, 1712–1722 (2014).
pubmed: 24665079
pmcid: 4248674
doi: 10.1002/art.38637
Raza, K. et al. Detection of antibodies to citrullinated tenascin-C in patients with early synovitis is associated with the development of rheumatoid arthritis. RMD Open 2, e000318 (2016).
pubmed: 27933208
pmcid: 5133409
doi: 10.1136/rmdopen-2016-000318
Song, J. et al. Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis. JCI Insight 6, e145217 (2021).
pubmed: 33507879
pmcid: 8021118
doi: 10.1172/jci.insight.145217
Pieper, J. et al. Memory T cells specific to citrullinated α-enolase are enriched in the rheumatic joint. J. Autoimmun. 92, 47–56 (2018).
pubmed: 29853344
pmcid: 8259322
doi: 10.1016/j.jaut.2018.04.004
Snir, O. et al. Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA–DRB1*0401–positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum. 63, 2873–2883 (2011).
pubmed: 21567378
pmcid: 3174345
doi: 10.1002/art.30445
Hill, J. A. et al. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J. Exp. Med. 205, 967–979 (2008).
pubmed: 18391064
pmcid: 2292232
doi: 10.1084/jem.20072051
Malmström, V., Catrina, A. I. & Klareskog, L. The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat. Rev. Immunol. 17, 60–75 (2017).
pubmed: 27916980
doi: 10.1038/nri.2016.124
Lim, J. J. et al. The shared susceptibility epitope of HLA-DR4 binds citrullinated self-antigens and the TCR. Sci. Immunol. 6, eabe0896 (2021).
pubmed: 33863750
doi: 10.1126/sciimmunol.abe0896
Koning, F., Thomas, R., Rossjohn, J. & Toes, R. E. Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens. Nat. Rev. Rheumatol. 11, 450–461 (2015).
pubmed: 25986717
doi: 10.1038/nrrheum.2015.59
Bang, H. et al. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum. 56, 2503–2511 (2007).
pubmed: 17665451
doi: 10.1002/art.22817
Mansour, H. E., Metwaly, K. M., Hassan, I. A., Elshamy, H. A. & Elbeblawy, M. M. Antibodies to mutated citrullinated vimentin in rheumatoid arthritis: diagnostic value, association with radiological damage and axial skeleton affection. Clin. Med. Insights Arthritis Musculoskelet. Disord. 3, 33–42 (2010).
pubmed: 21124694
pmcid: 2989636
doi: 10.4137/CMAMD.S4827
Mahdi, H. et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat. Genet. 41, 1319–1324 (2009).
pubmed: 19898480
doi: 10.1038/ng.480
Goldbach-Mansky, R. et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res. 2, 236–243 (2000).
pubmed: 11056669
pmcid: 17811
doi: 10.1186/ar93
Snir, O. et al. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann. Rheum. Dis. 68, 736–743 (2009).
pubmed: 18635594
doi: 10.1136/ard.2008.091355
Vander Cruyssen, B. et al. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res. Ther. 8, R122 (2006).
doi: 10.1186/ar2011
La Gruta, N. L. et al. Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. J. Clin. Invest. 120, 1885–1894 (2010).
pubmed: 20440073
pmcid: 2877949
doi: 10.1172/JCI41538
Moon, J. J. et al. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27, 203–213 (2007).
pubmed: 17707129
pmcid: 2200089
doi: 10.1016/j.immuni.2007.07.007
Rossjohn, J. et al. T cell antigen receptor recognition of antigen-presenting molecules. Annu. Rev. Immunol. 33, 169–200 (2015).
pubmed: 25493333
doi: 10.1146/annurev-immunol-032414-112334
Scally, S. W. et al. Molecular basis for increased susceptibility of Indigenous north Americans to seropositive rheumatoid arthritis. Ann. Rheum. Dis. 76, 1915–1923 (2017).
pubmed: 28801345
doi: 10.1136/annrheumdis-2017-211300
Sharma, R. K. et al. Biased TCR gene usage in citrullinated tenascin C specific T-cells in rheumatoid arthritis. Sci. Rep. 11, 24512 (2021).
pubmed: 34972837
pmcid: 8720095
doi: 10.1038/s41598-021-04291-8
Petersen, J. et al. T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease. Nat. Struct. Mol. Biol. 21, 480–488 (2014).
pubmed: 24777060
doi: 10.1038/nsmb.2817
Pathiraja, V. et al. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4
pubmed: 25157096
doi: 10.2337/db14-0858
Tran, M. T. et al. T cell receptor recognition of hybrid insulin peptides bound to HLA-DQ8. Nat. Commun. 12, 5110 (2021).
pubmed: 34433824
pmcid: 8387461
doi: 10.1038/s41467-021-25404-x
Wegner, N. et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 233, 34–54 (2010).
pubmed: 20192991
doi: 10.1111/j.0105-2896.2009.00850.x
van der Woude, D. et al. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann. Rheum. Dis. 69, 1554–1561 (2010).
pubmed: 20448290
doi: 10.1136/ard.2009.124537
Ito, K. et al. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J. Exp. Med. 183, 2635–2644 (1996).
pubmed: 8676084
doi: 10.1084/jem.183.6.2635
Dash, P. et al. Paired analysis of TCRalpha and TCRbeta chains at the single-cell level in mice. J. Clin. Invest. 121, 288–295 (2011).
pubmed: 21135507
doi: 10.1172/JCI44752
Wang, X., Spandidos, A., Wang, H. & Seed, B. PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update. Nucleic Acids Res. 40, D1144–D1149 (2012).
pubmed: 22086960
doi: 10.1093/nar/gkr1013
Brochet, X., Lefranc, M. P. & Giudicelli, V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36, W503–W508 (2008).
pubmed: 18503082
pmcid: 2447746
doi: 10.1093/nar/gkn316
Szymczak, A. L. et al. Correction of multi-gene deficiency in vivo using a single ‘self-cleaving’ 2A peptide-based retroviral vector. Nat. Biotechnol. 22, 589–594 (2004).
pubmed: 15064769
doi: 10.1038/nbt957
Boulter, J. M. et al. Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng. 16, 707–711 (2003).
pubmed: 14560057
doi: 10.1093/protein/gzg087
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of coot. Acta Crystallogr D. Biol. Crystallogr. 66, 486–501 (2010).
pubmed: 20383002
pmcid: 2852313
doi: 10.1107/S0907444910007493
Adams, P. D. et al. PHENIX: a comprehensive python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D. Biol. Crystallogr. 66, 213–221 (2010).
doi: 10.1107/S0907444909052925
Lefranc, M. P. et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev. Comp. Immunol. 27, 55–77 (2003).
pubmed: 12477501
doi: 10.1016/S0145-305X(02)00039-3